Compounded Tirzepatide vs BPC-157

An honest, side-by-side look at two treatment options — so you and your provider can decide what may work best for you.

How Do They Compare?

Compounded tirzepatide and BPC-157 address entirely different health goals. Tirzepatide is a dual GIP/GLP-1 receptor agonist designed to support weight management, while BPC-157 is a peptide being researched for potential tissue repair and recovery benefits. A licensed provider can help determine which treatments may be appropriate for your individual needs.

All medications referenced on this page are compounded by a licensed 503A pharmacy and are not FDA-approved.

Side-by-Side Comparison

Compounded Tirzepatide

Compounded Tirzepatide

Available Now
$285/mo

If prescribed by a provider

Category

weight-management

Description

Dual GIP/GLP-1 receptor agonist for weight management

Features

  • Targets two hormonal pathways (GIP and GLP-1)
  • May help reduce appetite through dual mechanism
  • Weekly subcutaneous injection
  • Dosage gradually titrated under medical supervision

Considerations

  • Compounded medications are not FDA-approved
  • Common side effects may include nausea, diarrhea, and decreased appetite
  • Not suitable for individuals with a history of MEN 2
  • Requires ongoing provider monitoring

Availability

Available Now
Get Started

BPC-157

Coming Soon
Coming Soon

Join the waitlist to be notified

Category

peptide

Description

Body protection compound for recovery

Features

  • Being studied for tissue repair support
  • May support gut health
  • Administered via subcutaneous injection
  • Research is ongoing

Considerations

  • Not FDA-approved
  • Limited clinical trial data in humans
  • Side effects not fully characterized
  • Requires provider supervision

Availability

Coming Soon
Join Waitlist

Frequently Asked Questions

Related Comparisons

vs

BPC-157 vs Pregnenolone

BPC-157 vs Pregnenolone: Which Is Right for You? | Vytora Health
vs

BPC-157 vs Dihexa

BPC-157 or Dihexa? What You Need to Know | Vytora Health
vs

BPC-157 vs Thymosin Alpha-1

BPC-157 vs Thymosin Alpha-1: Benefits, Cost, and Considerations | Vytora Health
vs

BPC-157 vs Methylene Blue

Comparing BPC-157 and Methylene Blue: Key Differences | Vytora Health
vs

BPC-157 vs AOD-9604

BPC-157 vs AOD-9604: A Side-by-Side Comparison | Vytora Health
vs

BPC-157 vs Lipo-MIC Injections

BPC-157 vs Lipo-MIC Injections: Which Is Right for You? | Vytora Health

Be the First to Know

One or more treatments on this page are coming soon. Join our waitlist to be notified when they become available, if prescribed by a provider.

Join the Waitlist

Dive Deeper

Learn more about Compounded Tirzepatide

Dual GIP/GLP-1 receptor agonist for weight management

Learn more about BPC-157

Body protection compound for recovery

Compounded medications are not FDA-approved. All treatments require evaluation and prescription by a licensed healthcare provider. Individual results may vary. This information is not intended to diagnose, treat, cure, or prevent any disease.

Ready to Explore Your Options?

Connect with a licensed provider who can help determine which treatment may be appropriate for your individual health goals.

Get Started

Ready to get started?

Talk to a licensed provider

Get Started